This paper is in the following e-collection/theme issue:

RCTs - Protocols/Proposals (eHealth) (538) Public (e)Health, Digital Epidemiology and Public Health Informatics (725)

Published on in Vol 5, No 1 (2016): Jan-Mar

Computerized Tailored Interventions to Enhance Prevention and Screening for Hepatitis C Virus Among People Who Inject Drugs: Protocol for a Randomized Pilot Study

Computerized Tailored Interventions to Enhance Prevention and Screening for Hepatitis C Virus Among People Who Inject Drugs: Protocol for a Randomized Pilot Study

Computerized Tailored Interventions to Enhance Prevention and Screening for Hepatitis C Virus Among People Who Inject Drugs: Protocol for a Randomized Pilot Study

Authors of this article:

Ryan P Westergaard1 Author Orcid Image ;   Shawnika J Hull2 Author Orcid Image ;   Alana Merkow1 Author Orcid Image ;   Laura K Stephens3 Author Orcid Image ;   Karli R Hochstatter1 Author Orcid Image ;   Heidi K Olson-Streed3 Author Orcid Image ;   Lisa M Baker1 Author Orcid Image ;   Timothy M Hess1 Author Orcid Image
Article Authors Cited by (8) Tweetations (3) Metrics

Journals

  1. Rowe C, Santos G, Raymond H, Coffin P. Social mixing and correlates of injection frequency among opioid use partnerships. International Journal of Drug Policy 2017;41:80 View
  2. Rockstroh J, Yazdanpanah Y. HepCare Europe: a new user-friendly hepatitis C care service model. What have we learned? What are the remaining challenges?. Journal of Antimicrobial Chemotherapy 2019;74(Supplement_5):v2 View
  3. Hochstatter K, Gustafson Sr D, Landucci G, Pe-Romashko K, Maus A, Shah D, Taylor Q, Gill E, Miller R, Krechel S, Westergaard R. A Mobile Health Intervention to Improve Hepatitis C Outcomes Among People With Opioid Use Disorder: Protocol for a Randomized Controlled Trial. JMIR Research Protocols 2019;8(8):e12620 View
  4. Hochstatter K, Hull S, Sethi A, Burns M, Mundt M, Westergaard R. Promoting Safe Injection Practices, Substance Use Reduction, Hepatitis C Testing, and Overdose Prevention Among Syringe Service Program Clients Using a Computer-Tailored Intervention: Pilot Randomized Controlled Trial. Journal of Medical Internet Research 2020;22(9):e19703 View
  5. Hochstatter K, Hull S, Stockman L, Stephens L, Olson-Streed H, Ehlenbach W, Repplinger M, Jacobs E, Westergaard R. Using database linkages to monitor the continuum of care for hepatitis C virus among syringe exchange clients: Experience from a pilot intervention. International Journal of Drug Policy 2017;42:22 View
  6. Rossi C, Butt Z, Wong S, Buxton J, Islam N, Yu A, Darvishian M, Gilbert M, Wong J, Chapinal N, Binka M, Alvarez M, Tyndall M, Krajden M, Janjua N. Hepatitis C virus reinfection after successful treatment with direct-acting antiviral therapy in a large population-based cohort. Journal of Hepatology 2018;69(5):1007 View
  7. Hochstatter K, Gustafson Sr D, Landucci G, Pe-Romashko K, Cody O, Maus A, Shah D, Westergaard R. Effect of an mHealth Intervention on Hepatitis C Testing Uptake Among People With Opioid Use Disorder: Randomized Controlled Trial. JMIR mHealth and uHealth 2021;9(2):e23080 View
  8. Reith M, Kortagere S, Wiers C, Sun H, Kurian M, Galli A, Volkow N, Lin Z. The dopamine transporter gene SLC6A3: multidisease risks. Molecular Psychiatry 2022;27(2):1031 View